Effect of the particle size of galactosylated lipoplex on hepatocyte-selective gene transfection after intraportal administration

被引:31
作者
Higuchi, Yuriko [1 ]
Kawakami, Shigeru [1 ]
Fumoto, Shintaro [1 ]
Yamashita, Furniyoshi [1 ]
Hashida, Mitsuru [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
关键词
gene delivery; hepatocyte; targeting; galactosylated liposome; drug delivery system;
D O I
10.1248/bpb.29.1521
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to examine the effect of the size of galactosylated cationic liposome (Gal-liposome)lplasmid DNA complex (Gal-lipoplex) on hepatocyte-selective gene transfection after intraportal administration. pCMV-Luc was selected as a model plasmid DNA. After intraportal administration of Gal-lipoplex to mice, the hepatic and intrahepatic gene expression was evaluated. To evaluate the effect of size, three different sizes of Gal-liposome were prepared. The mean particle sizes of Gal-lipoplex were about 141, 179, and 235 mn, respectively. The hepatic transfection efficacy was significantly enhanced by increasing the size of Gal-lipoplex. However, the gene expression in liver parenchymal cells (PC) of Gal-lipoplex of about 141 urn in size was significantly higher than that in liver non-parenchymal cells (NPC). In contrast, gene expression in PC of Gal-lipoplex of about 235 urn in size was significantly lower than that in NPC. These results highlight the importance of the Gal-lipoplex size for hepatocyte-selective gene transfer in vivo. The information in this study will be valuable for the future use, design, and development of Gal-lipoplex for in vivo applications.
引用
收藏
页码:1521 / 1523
页数:3
相关论文
共 18 条
[1]  
Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
[2]   Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex [J].
Fumoto, S ;
Kawakami, S ;
Shigeta, K ;
Higuchi, Y ;
Yamashita, F ;
Hashida, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02) :484-493
[3]   Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation [J].
Fumoto, S ;
Kawakami, S ;
Ito, Y ;
Shigeta, K ;
Yamashita, F ;
Hashida, M .
MOLECULAR THERAPY, 2004, 10 (04) :719-729
[4]   Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver [J].
Fumoto, S ;
Nakadori, F ;
Kawakami, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1452-1459
[5]   The effect of liposome size on the final lipid/DNA ratio of cationic lipoplexes [J].
Gonçalves, E ;
Debs, RJ ;
Heath, TD .
BIOPHYSICAL JOURNAL, 2004, 86 (03) :1554-1563
[6]   Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes [J].
Hwang, SH ;
Hayashi, K ;
Takayama, K ;
Maitani, Y .
GENE THERAPY, 2001, 8 (16) :1276-1280
[7]  
Kawakami S, 2002, CRIT REV THER DRUG, V19, P171
[8]   Enhanced gene expression in lung by a stabilized lipoplex using sodium chloride for complex formation [J].
Kawakami, S ;
Ito, Y ;
Fumoto, S ;
Yamashita, F ;
Hashida, M .
JOURNAL OF GENE MEDICINE, 2005, 7 (12) :1526-1533
[9]   In vivo gene delivery to the liver using novel galactosylated cationic liposomes [J].
Kawakami, S ;
Fumoto, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (03) :306-313
[10]   Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes [J].
Kawakami, S ;
Yamashita, F ;
Nishikawa, M ;
Takakura, Y ;
Hashida, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (01) :78-83